Cargando…
Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells
An activated AKT pathway underlies the pathogenesis of soft tissue sarcoma (STS), with over-expressed phosphorylated AKT (p-AKT) correlating with a poor prognosis in a subset of STS cases. Recently, eribulin, a microtubule dynamics inhibitor, has demonstrated efficacy and is approved in patients wit...
Autores principales: | Hayasaka, Naotaka, Takada, Kohichi, Nakamura, Hajime, Arihara, Yohei, Kawano, Yutaka, Osuga, Takahiro, Murase, Kazuyuki, Kikuchi, Shohei, Iyama, Satoshi, Emori, Makoto, Sugita, Shintaro, Hasegawa, Tadashi, Takasawa, Akira, Miyanishi, Koji, Kobune, Masayoshi, Kato, Junji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453888/ https://www.ncbi.nlm.nih.gov/pubmed/30962488 http://dx.doi.org/10.1038/s41598-019-42300-z |
Ejemplares similares
-
Pneumothorax as an Adverse Event in Patients with Lung Metastasis of Soft Tissue Sarcoma under Eribulin Treatment
por: Takada, Kohichi, et al.
Publicado: (2019) -
Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells
por: Okagawa, Yutaka, et al.
Publicado: (2016) -
The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma
por: Kamihara, Yusuke, et al.
Publicado: (2016) -
Exceptionally rapid response to pembrolizumab in a SMARCA4‐deficient thoracic sarcoma overexpressing PD‐L1: A case report
por: Takada, Kohichi, et al.
Publicado: (2019) -
Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and Implications of New Biomarkers
por: Nakamura, Hajime, et al.
Publicado: (2022)